Defining the contribution of the HLA region to cis DQ2-positive coeliac disease patients

Genes and Immunity

Volumn 5, Issue 3, 2004, Pages 215-220

  van Belzen, M J ^a   Koeleman, B P C ^a   Crusius, J B A ^b   Meijer, J W R ^c   Bardoel, A F J ^a   Pearson, P L ^a   Sandkuijl, L A ^d   Houwen, R H J ^a   Wijmenga, C ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c RIJNSTATE HOSPITAL   (Netherlands)

^d NONE

Author keywords

Association analysis; Coeliac disease; HLA region; Linkage disequilibrium

Indexed keywords

HLA DQ ANTIGEN;

ADOLESCENT; ADULT; ARTICLE; CELIAC DISEASE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE LOCUS; GENE TRANSFER; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HLA SYSTEM; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE MARKER; NETHERLANDS; PRIORITY JOURNAL; RISK FACTOR;

ADOLESCENT; CASE-CONTROL STUDIES; CELIAC DISEASE; FAMILY; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HETEROZYGOTE; HLA-DQ ANTIGENS; HOMOZYGOTE; HUMANS; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; RISK FACTORS;

EID: 3242748997     PISSN: 14664879     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gene.6364061     Document Type: Article

References (31)

1. Csizmadia CG, Mearin ML, von Blomberg BM, Brand R, Verloove-Vanhorick SP. An iceberg of childhood coeliac disease in the Netherlands. Lancet 1999; 353: 813-814.
2. Rostami K, Mulder CJ, Werre JM et al. High prevalence of celiac disease in apparently healthy blood donors suggests a high prevalence of undiagnosed celiac disease in the Dutch population. Scand J Gastroenterol 1999; 34: 276-279.
3. Rostami K, Kerckhaert J, Tiemessen R, von Blomberg BM, Meijer JW, Mulder CJ. Sensitivity of antiendomysium and antigliadin antibodies in untreated celiac disease: disappointing in clinical practice. Am J Gastroenterol 1999; 94: 888-894.
4. Marsh MN. Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity ('celiac sprue'). Gastroenterology 1992; 102: 330-354.
5. Farrell RJ, Kelly CP. Celiac sprue. N Engl J Med 2002; 346: 180-188.
6. Sollid LM, Thorsby E. HLA susceptibility genes in celiac disease: genetic mapping and role in pathogenesis. Gastroenterology 1993; 105: 910-922.
7. van de Wal Y, Kooy Y, van Veelen P et al. Selective deamidation by tissue transglutaminase strongly enhances gliadin-specific T cell reactivity. J Immunol 1998; 161: 1585-1588.
8. Molberg O, McAdam SN, Korner R et al. Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease. Nat Med 1998; 4: 713-717.
9. Alper CA, Fleischnick E, Awdeh Z, Katz AJ, Yunis EJ. Extended major histocompatibility complex haplotypes in patients with gluten-sensitive enteropathy. J Clin Invest 1987; 79: 251-256.
10. Candore G, Lio D, Colonna Romano G, Caruso C. Pathogenesis of autoimmune diseases associated with 8.1 ancestral haplotype: effect of multiple gene interactions. Autoimmun Rev 2002; 1: 29-35.
11. Louka AS, Nilsson S, Olsson M et al. HLA in coeliac disease families: a novel test of risk modification by the 'other' haplotype when at least one DQA1*05-DQB1*02 haplotype is carried. Tissue Antigens 2002; 60: 147-154.
12. Ploski R, Ek J, Thorsby E, Sollid LM. On the HLA-DQ(alpha 1*0501, beta 1*0201)-associated susceptibility in celiac disease: a possible gene dosage effect of DQB1*0201. Tissue Antigens 1993; 41: 173-177.
13. Mearin ML, Biemond I, Pena AS et al. HLA-DR phenotypes in Spanish coeliac children: their contribution to the understanding of the genetics of the disease. Gut 1983; 24: 532-537.
14. Mearin ML, Bouquet J, Mourad N et al. HLA-DR antigens and phenotypes in Dutch coeliac children and their families. Clin Genet 1985; 27: 45-50.
15. Bolognesi E, Karell K, Percopo S et al. Additional factor in some HLA DR3/DQ2 haplotypes confers a fourfold increased genetic risk of celiac disease. Tissue Antigens 2003; 61: 308-316.
16. Lopez-Vazquez A, Rodrigo L, Fuentes D et al. MHC class I chain related gene A (MICA) modulates the development of coeliac disease in patients with the high risk heterodimer DQA1*0501/DQB1* 0201. Gut 2002; 50: 336-340.
17. Rueda B, Pascual M, Lopez-Nevot MA et al. Association of MICA-A5.1 allele with susceptibility to celiac disease in a family study. Am J Gastroenterol 2003; 98: 359-362.
18. McManus R, Wilson AG, Mansfield J, Weir DG, Duff GW, Kelleher D. TNF2, a polymorphism of the tumour necrosis-alpha gene promoter, is a component of the celiac disease major histocompatibility complex haplotype. Eur J Immunol 1996; 26: 2113-2118.
19. Louka AS, Lie BA, Talseth B et al. Coeliac disease patients carry conserved HLA-DR3-DQ2 haplotypes revealed by association of TNF alleles. Immunogenetics 2003; 55: 339-343.
20. Garrote JA, Arranz E, Telleria JJ, Castro J, Calvo C, Blanco-Quiros A. TNF alpha and LT alpha gene polymorphisms as additional markers of celiac disease susceptibility in a DQ2-positive population. Immunogenetics 2002; 54: 551-555.
21. de la Concha EG, Fernandez-Arquero M, Vigil P et al. Celiac disease and TNF promoter polymorphisms. Hum Immunol 2000; 61: 513-517.
22. Bolognesi E, Dalfonso S, Rolando V, Fasano ME, Pratico L, Momigliano-Richiardi P. MICA and MICB microsatellite alleles in HLA extended haplotypes. Eur J Immunogenet 2001; 28: 523-530.
23. Grimaldi MC, Clayton J, Pontarotti P, Cambon-Thomsen A, Crouau-Roy B. New highly polymorphic microsatellite marker in linkage disequilibrium with HLA-B. Hum Immunol 1996; 51: 89-94.
24. Polvi A, Maki M, Partanen J. Celiac patients predominantly inherit HLA-DPB1*0101 positive haplotype from HLA-DQ2 homozygous parent. Hum Immunol 1997; 53: 156-158.
25. Lie BA, Sollid LM, Ascher H et al. A gene telomeric of the HLA class I region is involved in predisposition to both type 1 diabetes and coeliac disease. Tissue Antigens 1999; 54: 162-168.
26. Thomson G. Mapping disease genes: family-based association studies. Am J Hum Genet 1995; 57: 487-498.
27. Louka AS, Moodie SJ, Karell K et al. A collaborative European search for non-DQA1*05-DQB1*02 celiac disease loci on HLA-DR3 haplotypes: analysis of transmission from homozygous parents. Hum Immunol 2003; 64: 350-358.
28. Congia M, Frau F, Lampis R et al. A high frequency of the A30, B18, DR3, DRw52, DQw2 extended haplotype in Sardinian celiac disease patients: further evidence that disease susceptibility is conferred by DQ A1*0501, B1*0201. Tissue Antigens 1992; 39: 78-83.
29. Vader W, Stepniak D, Kooy Y et al. The HLA-DQ2 gene dose effect in celiac disease is directly related to the magnitude and breadth of gluten-specific T cell responses. Proc Natl Acad Sci USA 2003; 100: 12390-12395.
30. Carrington M, Miller T, White M et al. Typing of HLA-DQA1 and DQB1 using DNA single-strand conformation polymorphism. Hum Immunol 1992; 33: 208-212.
31. Koeleman BP, Dudbridge F, Cordell HJ, Todd JA. Adaptation of the extended transmission/disequilibrium test to distinguish disease associations of multiple loci: the conditional extended transmission/disequilibrium test. Ann Hum Genet 2000; 64: 207-213.